rs761628767
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM1PM5PP3
The NM_014249.4(NR2E3):c.926G>A(p.Arg309Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000013 in 1,613,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R309W) has been classified as Likely pathogenic.
Frequency
Consequence
NM_014249.4 missense
Scores
Clinical Significance
Conservation
Publications
- retinitis pigmentosa 37Inheritance: AD, AR Classification: DEFINITIVE, STRONG, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- enhanced S-cone syndromeInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Goldmann-Favre syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NR2E3 | ENST00000617575.5 | c.926G>A | p.Arg309Gln | missense_variant | Exon 6 of 8 | 1 | NM_014249.4 | ENSP00000482504.1 | ||
| NR2E3 | ENST00000621098.1 | c.926G>A | p.Arg309Gln | missense_variant | Exon 6 of 7 | 1 | ENSP00000479962.1 | |||
| NR2E3 | ENST00000621736.4 | c.662G>A | p.Arg221Gln | missense_variant | Exon 8 of 10 | 2 | ENSP00000479254.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152232Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000124 AC: 3AN: 241588 AF XY: 0.0000152 show subpopulations
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461600Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 6AN XY: 727080 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152232Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74368 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 309 of the NR2E3 protein (p.Arg309Gln). This variant is present in population databases (rs761628767, gnomAD 0.003%). This missense change has been observed in individual(s) with autosomal recessive enhanced S-cone syndrome (PMID: 32679203). ClinVar contains an entry for this variant (Variation ID: 1355514). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt NR2E3 protein function with a negative predictive value of 80%. This variant disrupts the p.Arg309 amino acid residue in NR2E3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10655056, 15459973, 19718767; internal data). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at